{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:05:22Z","timestamp":1784217922055,"version":"3.55.0"},"reference-count":62,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"British Heart Foundation Birmingham Accelerator","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"DOI":"10.13039\/501100018952","name":"Birmingham Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203326"],"award-info":[{"award-number":["NIHR203326"]}],"id":[{"id":"10.13039\/501100018952","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC Health Data Research UK","award":["HDRUK\/CFC\/01"],"award-info":[{"award-number":["HDRUK\/CFC\/01"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101095480"],"award-info":[{"award-number":["101095480"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NHS Data for R&D Subnational Secure Data Environment programme","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"The Cook & Wolstenholme Charitable Trust","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"UKRI Horizon Europe Guarantee scheme","award":["10061996"],"award-info":[{"award-number":["10061996"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Blood pressure treatment response is variable in individual patients, and the choice of medical therapy is often dependent on clinician experience. Treatment choices could be personalised by patient empowerment and metabolomic profiles, and augmented by machine learning, but robust evaluation is lacking on how these can be combined to enhance clinical effectiveness. The HYPERMARKER trial will evaluate how an individualised choice of medication class can address the avoidable global health and economic burdens of hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The HYPERMARKER trial is a proof-of-concept, pragmatic, multicentre, adaptive, open-label strategy trial embedded into routine clinical practice with stratified individual patient randomisation. The trial was co-designed with a patient and public involvement team. The intervention is a digital portal that supports shared decision-making on hypertension therapy class using clinical features plus metabolomic profiles determined with liquid chromatography-mass spectrometry.<\/jats:p>\n                    <jats:p>Eligible patients are aged\u226518 years with a systolic blood pressure\u2265140\u2009mm Hg and a clinical indication for antihypertensive therapy. 400 participants will be randomised to the usual standard of care for treatment selection or to the intervention group. Remote follow-up will occur through a patient smartphone application and linked blood pressure monitor to assess the primary outcome of change in home systolic blood pressure during a 4-week period after medication changes. Secondary outcomes will include patient-reported adverse effects and quality of life, treatment withdrawal, healthcare utilisation and a health economic analysis. In the second phase of the trial, all participants will receive an updated version of the intervention regardless of the original randomised group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval will be obtained for all sites. Approval in England: North West \u2013 Greater Manchester West Research Ethics Committee (REC) (25\/NW\/0296). Trial results will be disseminated via peer-reviewed publications and plain-language patient summaries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT07294794\">NCT07294794<\/jats:ext-link>\n                      and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN29385951\">ISRCTN29385951<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-117869","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:25:20Z","timestamp":1784215520000},"page":"e117869","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Personalised approach to hypertension treatment: protocol for the HYPERMARKER randomised controlled trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07294794","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn29385951","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct07294794","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn29385951","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4266-8332","authenticated-orcid":false,"given":"Matthew","family":"Chapman","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Birmingham, Birmingham, England, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Knikman","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Mobley","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Birmingham, Birmingham, England, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Lagerwaard","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Martinez-Garcia","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hypertension Unit, Clinical Hospital of Valencia, Valencia, Spain"},{"name":"Cardiometabolic Research Group, Research Institute of the Clinical Hospital of Valencia (INCLIVA), Valencia, Spain"},{"name":"University of Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraphine","family":"Zeitouny","sequence":"additional","affiliation":[{"name":"London School of Economics and Political Science, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6258","authenticated-orcid":false,"given":"Daniel","family":"Engler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate B","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Spiering","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Champsi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Birmingham, Birmingham, England, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W","family":"Carter","sequence":"additional","affiliation":[{"name":"London School of Economics and Political Science, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[{"name":"Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick","family":"Grobbee","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-9812","authenticated-orcid":false,"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Birmingham, Birmingham, England, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2026071608251330000_16.7.e117869.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1"},{"key":"2026071608251330000_16.7.e117869.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018912"},{"key":"2026071608251330000_16.7.e117869.3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30752-2"},{"key":"2026071608251330000_16.7.e117869.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-013-0554-4"},{"key":"2026071608251330000_16.7.e117869.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"2026071608251330000_16.7.e117869.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178"},{"key":"2026071608251330000_16.7.e117869.7","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065"},{"key":"2026071608251330000_16.7.e117869.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"2026071608251330000_16.7.e117869.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39553.670231.25"},{"key":"2026071608251330000_16.7.e117869.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.830299"},{"key":"2026071608251330000_16.7.e117869.11","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835e2286"},{"key":"2026071608251330000_16.7.e117869.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n189","article-title":"Association between antihypertensive treatment and adverse events: systematic review and meta-analysis","volume":"372","author":"Albasri","year":"2021","journal-title":"BMJ"},{"key":"2026071608251330000_16.7.e117869.13","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpab137"},{"key":"2026071608251330000_16.7.e117869.14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032197","article-title":"Trends of Antihypertensive Prescription Among US Adults From 2010 to 2019 and Changes Following Treatment Guidelines: Analysis of Multicenter Electronic Health Records","volume":"13","author":"Lin","year":"2024","journal-title":"JAHA"},{"key":"2026071608251330000_16.7.e117869.15","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11308"},{"key":"2026071608251330000_16.7.e117869.16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32317-7"},{"key":"2026071608251330000_16.7.e117869.17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036557","article-title":"Trends in Initial Antihypertensive Medication Prescribing Among >2.8\u2009Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019","volume":"13","author":"Xu","year":"2024","journal-title":"JAHA"},{"key":"2026071608251330000_16.7.e117869.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003674","article-title":"Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study","volume":"18","author":"Tran","year":"2021","journal-title":"PLoS Med"},{"key":"2026071608251330000_16.7.e117869.19","first-page":"202","article-title":"Hypertension awareness, treatment and control among ethnic minority populations in Europe: a systematic review and meta-analysis","volume":"39","author":"van der Linden","year":"2021","journal-title":"J Hypertens (Los Angel)"},{"key":"2026071608251330000_16.7.e117869.20","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320171"},{"key":"2026071608251330000_16.7.e117869.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1595"},{"key":"2026071608251330000_16.7.e117869.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901113"},{"key":"2026071608251330000_16.7.e117869.23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/jch.13094","article-title":"Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension","volume":"19","author":"Mehanna","year":"2017","journal-title":"J of Clinical Hypertension"},{"key":"2026071608251330000_16.7.e117869.24","first-page":"1278","article-title":"Differences in hypertension phenotypes between Africans and Europeans: role of environment","volume":"38","author":"Faconti","year":"2020","journal-title":"J Hypertens (Los Angel)"},{"key":"2026071608251330000_16.7.e117869.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.3322"},{"key":"2026071608251330000_16.7.e117869.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1427"},{"key":"2026071608251330000_16.7.e117869.27","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-016-1094-6"},{"key":"2026071608251330000_16.7.e117869.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2014.22","article-title":"Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability","volume":"3","author":"Ellero\u2010Simatos","year":"2014","journal-title":"CPT Pharmacom & Syst Pharma"},{"key":"2026071608251330000_16.7.e117869.29","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehag165","article-title":"Transforming clinical decisions with artificial intelligence: the HYPERMARKER project","volume":"47","author":"Kotecha","year":"2026","journal-title":"Eur Heart J"},{"key":"2026071608251330000_16.7.e117869.30","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2007000200012"},{"key":"2026071608251330000_16.7.e117869.31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(05)17965-3","article-title":"A proposed charter for clinical trial data monitoring committees: helping them to do their job well","volume":"365","author":"Group","year":"2005","journal-title":"The Lancet"},{"key":"2026071608251330000_16.7.e117869.32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2026071608251330000_16.7.e117869.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21903"},{"key":"2026071608251330000_16.7.e117869.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21243"},{"key":"2026071608251330000_16.7.e117869.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069048","article-title":"CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research","volume":"378","author":"Kotecha","year":"2022","journal-title":"BMJ"},{"key":"2026071608251330000_16.7.e117869.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1034-x"},{"key":"2026071608251330000_16.7.e117869.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07614-4"},{"key":"2026071608251330000_16.7.e117869.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2014.11.009"},{"key":"2026071608251330000_16.7.e117869.39","first-page":"1","article-title":"A Nested Case-Control Study of Association between Metabolome and Hypertension Risk","volume":"2016","author":"Hao","year":"2016","journal-title":"Biomed Res Int"},{"key":"2026071608251330000_16.7.e117869.40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/HYPERTENSIONAHA.116.07292","article-title":"Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation Into Cancer and Nutrition\u2013Potsdam Study","volume":"68","author":"Dietrich","year":"2016","journal-title":"Hypertension"},{"key":"2026071608251330000_16.7.e117869.41","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1284114","article-title":"Metabolomic profiling reveals key metabolites associated with hypertension progression","volume":"11","author":"Al Ashmar","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"2026071608251330000_16.7.e117869.42","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-024-02182-3","article-title":"Identification of novel hypertension biomarkers using explainable AI and metabolomics","volume":"20","author":"Sekaran","year":"2024","journal-title":"Metabolomics"},{"key":"2026071608251330000_16.7.e117869.43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032643","article-title":"Sex\u2010Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort","volume":"13","author":"Couch","year":"2024","journal-title":"JAHA"},{"key":"2026071608251330000_16.7.e117869.44","first-page":"1302","article-title":"An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study","volume":"38","author":"He","year":"2020","journal-title":"J Hypertens (Los Angel)"},{"key":"2026071608251330000_16.7.e117869.45","doi-asserted-by":"crossref","first-page":"104276","DOI":"10.1016\/j.ebiom.2022.104276","article-title":"Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study","volume":"84","author":"Reel","year":"2022","journal-title":"EBioMedicine"},{"key":"2026071608251330000_16.7.e117869.46","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111568","article-title":"Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication","volume":"16","author":"Jian","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026071608251330000_16.7.e117869.47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/HYPERTENSIONAHA.123.20901","article-title":"Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions","volume":"80","author":"Kim","year":"2023","journal-title":"Hypertension"},{"key":"2026071608251330000_16.7.e117869.48","doi-asserted-by":"crossref","unstructured":"Weng L , Gong Y , Culver J , et al . Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol. Metabolomics 2016;12. doi:10.1007\/s11306-016-1098-2","DOI":"10.1007\/s11306-016-1098-2"},{"key":"2026071608251330000_16.7.e117869.49","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(21)01638-X","article-title":"Redefining \u03b2-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis","volume":"398","author":"Karwath","year":"2021","journal-title":"The Lancet"},{"key":"2026071608251330000_16.7.e117869.50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac758"},{"key":"2026071608251330000_16.7.e117869.51","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1016\/S2589-7500(22)00170-4","article-title":"Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials","volume":"4","author":"Oikonomou","year":"2022","journal-title":"Lancet Digit Health"},{"key":"2026071608251330000_16.7.e117869.52","doi-asserted-by":"crossref","first-page":"101841","DOI":"10.1016\/j.artmed.2020.101841","article-title":"Characterizing the critical features when personalizing antihypertensive drugs using spectrum analysis and machine learning methods","volume":"104","author":"Chunyu","year":"2020","journal-title":"Artif Intell Med"},{"key":"2026071608251330000_16.7.e117869.53","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.396","article-title":"Machine learning of big data in gaining insight into successful treatment of hypertension","volume":"6","author":"Koren","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"2026071608251330000_16.7.e117869.54","doi-asserted-by":"crossref","unstructured":"Wang F , Beecy A . Implementing AI models in clinical workflows: a roadmap. BMJ EBM 2023;bmjebm\u20132023. doi:10.1136\/bmjebm-2023-112727","DOI":"10.1136\/bmjebm-2023-112727"},{"key":"2026071608251330000_16.7.e117869.55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/europace\/eux299","article-title":"European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers","volume":"20","author":"Kotecha","year":"2018","journal-title":"EP Europace"},{"key":"2026071608251330000_16.7.e117869.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2016.12.012"},{"key":"2026071608251330000_16.7.e117869.57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m4858","article-title":"Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial","volume":"372","author":"McManus","year":"2021","journal-title":"BMJ"},{"key":"2026071608251330000_16.7.e117869.58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030749","article-title":"Personalized Antihypertensive Treatment Optimization With Smartphone\u2010Enabled Remote Precision Dosing of Amlodipine During the COVID\u201019 Pandemic (PERSONAL\u2010CovidBP Trial)","volume":"13","author":"Collier","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026071608251330000_16.7.e117869.59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002389","article-title":"Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis","volume":"14","author":"Tucker","year":"2017","journal-title":"PLoS Med"},{"key":"2026071608251330000_16.7.e117869.60","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000803"},{"key":"2026071608251330000_16.7.e117869.61","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.221473"},{"key":"2026071608251330000_16.7.e117869.62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2023-100971","article-title":"Achieving large-scale clinician adoption of AI-enabled decision support","volume":"31","author":"Scott","year":"2024","journal-title":"BMJ Health Care Inform"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-117869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:25:26Z","timestamp":1784215526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-117869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,16]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-117869"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-117869","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}